Karl Egerer

3.4k citations

52 papers · 2.5k indexed · h-index 26

Impact in

Rheumatology top 1%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Immunology top 5%
- T-cell and B-cell Immunology

Papers in ⓘ

Rheumatology 20
- Systemic Lupus Erythematosus Research 13
- Rheumatoid Arthritis Research and Therapies 11
Immunology 21
- Galectins and Cancer Biology 7

Co-authors: Eugen Feist (27 shared papers)Thomas Dörner (9 shared papers)Gerd R Burmester (12 shared papers)Andrew J.S. Coats (3 shared papers)Wolfgang J. Kox (3 shared papers)Hans‐Dieter Volk (2 shared papers)G.-R. Burmester (9 shared papers)Stefan D. Anker (1 shared paper)
Journals: Arthritis Research & Therapy (9 papers)Annals of the Rheumatic Diseases (6 papers)Blood (3 papers)The Journal of Rheumatology (2 papers)Basic Research in Cardiology (2 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Karl Egerer

51 papers receiving 2.4k citations

Peers

Countries citing papers authored by Karl Egerer

Since Specialization

Citations

This map shows the geographic impact of Karl Egerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Egerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Egerer more than expected).

Fields of papers citing papers by Karl Egerer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Egerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Egerer. The network helps show where Karl Egerer may publish in the future.

Co-authors

The 25 scholars most cited alongside Karl Egerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karl Egerer Line = papers co-authored together Karl Egerer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Elevated soluble CD14 receptors and altered cytokines in chronic heart failure The American Journal of Cardiology ·Stefan D. Anker, Karl Egerer, Hans‐Dieter Volk, Wolfgang J. Kox, Philip A. Poole-Wilson, Andrew J.S. Coats	1997	310
2	Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis Arthritis & Rheumatism ·Holger Bang, Karl Egerer, Anke Gauliard, Kirsten Lüthke, Paul Rudolph, G Fredenhagen, Wigbert Berg, Eugen Feist, G.-R. Burmester	2007	234
3	Rheumatoid factor revisited Current Opinion in Rheumatology ·Thomas Dörner, Karl Egerer, Eugen Feist, Gerd R Burmester	2004	174
4	Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study Annals of the Rheumatic Diseases ·J. Detert, H. Bastian, Joachim Listing, Anja Weiß, Siegfried Wassenberg, Anke Liebhaber, Karin Rockwitz, Rieke Alten, Klaus Krüger, Rolf Rau, Christina Simon, Eva Gremmelsbacher, T. Braun, Bettina Marsmann, V. Höhne-Zimmer, Karl Egerer, Frank Buttgereit, G.-R. Burmester	2012	153
5	Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. PubMed ·Karl Egerer, Ulrike Kuckelkorn, Paul Rudolph, Jens C. Rückert, Thomas Dörner, Gerd R Burmester, Peter M. Kloetzel, Eugen Feist	2002	109
6	Hyperprocalcitonemia in Patients with Noninfectious SIRS and Pulmonary Dysfunction Associated with Cardiopulmonary Bypass Anesthesiology ·Mario Hensel, Thomas Volk, W D Döcke, Florian Kern, Dirk Tschirna, Karl Egerer, Wolfgang Konertz, Wolfgang J. Kox	1998	105
7	Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma Blood ·Christian Jakob, Karl Egerer, Peter Liebisch, Seval Türkmen, Ivana Zavrski, Ulrike Kuckelkorn, Ulrike Heider, Martin Kaiser, Claudia Fleissner, Jan Sterz, Lorenz Kleeberg, Eugen Feist, Gerd-R. Burmester, Peter-M. Kloetzel, Orhan Sezer	2006	104
8	Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests Arthritis Research & Therapy ·Karl Egerer, Dirk Roggenbuck, Rico Hiemann, Max-Georg Weyer, Thomas Büttner, Boris Radau, Rosemarie Krause, B. Lehmann, Eugen Feist, Gerd‐Rüdiger Burmester	2010	95
9	Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus Lupus ·Karl Egerer, E Feist, Ute Rohr, (unknown), GR Burmester, Thomas Dörner	2000	94
10	Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia European Journal of Endocrinology ·Wolfram Doehner, C.D. Pflaum, Mathias Rauchhaus, IF Godsland, Karl Egerer, Mariantonietta Cicoira, VG Florea, Rakesh Sharma, AP Bolger, AJ Coats, SD Anker, CJ Strasburger	2001	88
11	Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients Arthritis Research & Therapy ·Katharina Hanke, Claudia Brückner, Cornelia Dähnrich, Dörte Huscher, Lars Komorowski, Wolfgang Meyer, Anthonia Janssen, Marina Backhaus, Mike Oliver Becker, Angela Kill, Karl Egerer, Gerd R Burmester, Falk Hiepe, Wolfgang Schlumberger, Gabriela Riemekasten	2009	85
12	Circulating Proteasomes Are Functional and Have a Subtype Pattern Distinct from 20S Proteasomes in Major Blood Cells Clinical Chemistry ·Annette Zoeger, Michael Blau, Karl Egerer, Eugen Feist, Burkhardt Dahlmann	2006	77
13	Very low monocytic HLA-DR expression indicates high risk of infection - immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy European Journal of Emergency Medicine ·K. Asadullah, Christian Woiciechowsky, W-D D CKE, Karl Egerer, W. J. Kox, Steven Vogel, Wolfram Sterry, Hans‐Dieter Volk	1995	69
14	Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure QJM ·Stefan D. Anker, Maurizio Volterrani, Karl Egerer, Carl V. Felton, W. J. Kox, P A Poole-Wilson, Andrew J.S. Coats	1998	64
15	Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha International Journal of Cardiology ·Wolfram Doehner, Mathias Rauchhaus, Ian F. Godsland, Karl Egerer, Josef Niebauer, Rakesh Sharma, Mariantonietta Cicoira, Viorel G. Florea, Andrew J.S. Coats, Stefan D. Anker	2002	59
16	Tissue‐specific up‐regulation of the proteasome subunit β5i (LMP7) in Sjögren's syndrome Arthritis & Rheumatism ·Thomas Egerer, Lorena Martinez‐Gamboa, Anja Dankof, Bruno Stuhlmüller, Thomas Dörner, Veit Krenn, Karl Egerer, Paul Rudolph, G.-R. Burmester, Eugen Feist	2006	56
17	A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis Annals of the Rheumatic Diseases ·Jan Damoiseaux, Cornelia Dähnrich, Anke Rosemann, Christian Probst, Lars Komorowski, Coen A. Stegeman, Karl Egerer, Falk Hiepe, Pieter van Paassen, W. Stöcker, W Schlumberger, J. W. Cohen Tervaert	2008	46
18	The Serological Diagnosis of Rheumatoid Arthritis Deutsches Ärzteblatt international ·Karl Egerer, Eugen Feist, Gerd‐Rüdiger Burmester	2009	42
19	Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort Arthritis Research & Therapy ·Katharina Hanke, Cornelia Dähnrich, Claudia Brückner, Dörte Huscher, Mike Oliver Becker, Anthonina Jansen, Wolfgang Meyer, Karl Egerer, Falk Hiepe, Gerd R Burmester, Wolfgang Schlumberger, Gabriela Riemekasten	2009	41
20	Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV). PubMed ·Christopher Schneeweis, Michael Rafalowicz, Eugen Feist, Frank Buttgereit, Paul-E Rudolph, G.-R. Burmester, Karl Egerer	2010	40

About Karl Egerer

Karl Egerer is a scholar working on Rheumatology, Immunology, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 52 papers that have together received 2.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Systemic Lupus Erythematosus Research (13 papers), Rheumatoid Arthritis Research and Therapies (11 papers), Ubiquitin and proteasome pathways (11 papers), Galectins and Cancer Biology (7 papers), Glycosylation and Glycoproteins Research (6 papers), Cell Adhesion Molecules Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Rheumatology (900 citations), Immunology (650 citations), Hematology (231 citations), Radiology, Nuclear Medicine and Imaging (418 citations) and Cardiology and Cardiovascular Medicine (379 citations). Karl Egerer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Eugen Feist, Thomas Dörner, Gerd R Burmester, Andrew J.S. Coats, Wolfgang J. Kox, Hans‐Dieter Volk, G.-R. Burmester, Stefan D. Anker, Paul Rudolph and Gerd‐Rüdiger Burmester. Their work appears in journals such as Arthritis Research & Therapy, Annals of the Rheumatic Diseases, Blood, The Journal of Rheumatology and Basic Research in Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact